Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Venous Thrombosis

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 113 articles: HTML format

Single Articles

April 2024
1. DANILATOU V, Dimopoulos D, Kostoulas T, Douketis J, et al
   Machine learning-based predictive models for patients with venous thromboembolism: A Systematic Review.
   Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4758.
   PubMed     Abstract available
   
   
   February 2024
2. DU HC, Zheng YF, Shen MQ, Deng BY, et al
   No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study.
   Thromb Haemost. 2024 Feb 22. doi: 10.1055/s-0044-1781425.
   PubMed     Abstract available
   
   
   
3. YU J, Wang T, Zhang X, Chen Q, et al
   Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
   Thromb Haemost. 2024;124:108-121.
   PubMed     Abstract available
   
   
   January 2024
4. COHEN AT, Creeper KJ, Alikhan R, Er C, et al
   Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer.
   Thromb Haemost. 2024 Jan 9. doi: 10.1055/s-0043-1778642.
   PubMed     Abstract available
   
   
   December 2023
5. HU T, Su P, Yang F, Ying J, et al
   Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
   Thromb Haemost. 2023 Dec 18. doi: 10.1055/s-0043-1777351.
   PubMed     Abstract available
   
   
   
6. STEINER D, Horvath-Puho E, Jorgensen H, Laugesen K, et al
   Risk of depression after venous thromboembolism in patients with hematological cancer: A population-based cohort study.
   Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5428.
   PubMed     Abstract available
   
   
   
7. UJUETA F
   Dietary manganese and the incidence of venous thromboembolism: Evidence for minerals and vitamins and comorbidities linked to venous thromboembolism.
   Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5513.
   PubMed     Abstract available
   
   
   November 2023
8. HUANG Y, Zhang Y, Yang S, Xiang H, et al
   Association and pathways between dietary manganese intake and incident venous thromboembolism.
   Thromb Haemost. 2023 Nov 20. doi: 10.1055/a-2213-8939.
   PubMed     Abstract available
   
   
   October 2023
9. SIGUENZA P, Lopez Nunez JJ, Falga Tirado C, Gomez-Cuervo C, et al
   Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency.
   Thromb Haemost. 2023 Oct 13. doi: 10.1055/a-2191-7510.
   PubMed     Abstract available
   
   
   
10. DIX C, Moloney M, Tran H, McFayden J, et al
    Venous thromboembolism and estrogen-containing gender-affirming hormone therapy.
    Thromb Haemost. 2023 Oct 10. doi: 10.1055/a-2188-8898.
    PubMed     Abstract available
    
    
    
11. HUSSAINI P, Larsen TL, Ghanima W, Dahm AEA, et al
    Risk factors for bleeding in cancer patients treated with conventional dose followed by low dose apixaban for venous thromboembolism.
    Thromb Haemost. 2023 Oct 10. doi: 10.1055/a-2188-8773.
    PubMed     Abstract available
    
    
    
12. MARTIN KA, Zakai NA
    Venous Thromboembolism and Obesity: Moving Toward a Better Understanding of the Population-Attributable Risk.
    Thromb Haemost. 2023 Oct 9. doi: 10.1055/s-0043-1776010.
    PubMed    
    
    
    
13. GOLDHABER SZ
    Obesity and Pulmonary Embolism: Can we Dismantle the "Obesity Paradox".
    Thromb Haemost. 2023 Oct 6. doi: 10.1055/a-2187-0966.
    PubMed     Abstract available
    
    
    September 2023
14. ROLDAN V, Soler-Espejo E, Marin F
    Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1775582.
    PubMed    
    
    
    August 2023
15. KONSTANTINIDES S
    Kidney Disease and Cancer Risk in Patients with Venous Thromboembolism: What Does it Mean for Clinical Practice?
    Thromb Haemost. 2023 Aug 11. doi: 10.1055/a-2152-4762.
    PubMed     Abstract available
    
    
    
16. FRISCHMUTH T, Tondel BG, Braekkan SK, Hansen JB, et al
    The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromso Study.
    Thromb Haemost. 2023 Aug 7. doi: 10.1055/s-0043-1772212.
    PubMed     Abstract available
    
    
    
17. COHEN AT, Wallenhorst C, Choudhuri S, Nassar A, et al
    A novel risk prediction score for clinically significant bleeding in patients anticoagulated for venous thromboembolism with active cancer.
    Thromb Haemost. 2023 Aug 1. doi: 10.1055/a-2145-7238.
    PubMed     Abstract available
    
    
    July 2023
18. CHAN N, Germini F
    Patterns and persistence of anticoagulant use in the treatment of venous thromboembolism: insights from South Korea.
    Thromb Haemost. 2023 Jul 18. doi: 10.1055/a-2131-7066.
    PubMed     Abstract available
    
    
    
19. CHAN N, Xu K
    Risk factors for venous thromboembolism in women of childbearing age.
    Thromb Haemost. 2023 Jul 7. doi: 10.1055/a-2125-3290.
    PubMed     Abstract available
    
    
    
20. QIAO L, Yao Y, Wu D, Xu R, et al
    The validation and modification of the Caprini risk assessment model (RAM) for evaluating venous thromboembolism (VTE) after joint arthroplasty.
    Thromb Haemost. 2023 Jul 4. doi: 10.1055/a-2122-7780.
    PubMed     Abstract available
    
    
    
21. KHORANA AA
    Immune Checkpoint Inhibitors And Venous Thromboembolism: The More Things Change....
    Thromb Haemost. 2023 Jul 3. doi: 10.1055/a-2121-9679.
    PubMed     Abstract available
    
    
    June 2023
22. GAUGLER JO, Righini M, Robert-Ebadi H, Sanchez O, et al
    Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism.
    Thromb Haemost. 2023 Jun 12. doi: 10.1055/s-0043-57018.
    PubMed     Abstract available
    
    
    
23. YOON D, Jeong HE, Choi S, Shin JY, et al
    Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort Study.
    Thromb Haemost. 2023 Jun 7. doi: 10.1055/a-2107-0815.
    PubMed     Abstract available
    
    
    
24. TSAI CT, Chao TF
    Incidence and Risk Factors for Pregnancy-Associated Venous Thromboembolism: Are There Differences between East and West?
    Thromb Haemost. 2023 Jun 5. doi: 10.1055/s-0043-1769736.
    PubMed    
    
    
    
25. GRANDONE E, Antonucci E, Colaizzo D, De Laurenzo A, et al
    Venous thromboembolism in women of childbearing age: insights from the START registry.
    Thromb Haemost. 2023 Jun 1. doi: 10.1055/s-0043-1769592.
    PubMed     Abstract available
    
    
    May 2023
26. LE SEVE JD, Guedon AF, Bordenave S, Agard C, et al
    Risk Factors of Venous Thromboembolic Disease in Cancer Patients Treated with Immune Checkpoint Inhibitor.
    Thromb Haemost. 2023 May 31. doi: 10.1055/s-0043-1769609.
    PubMed     Abstract available
    
    
    
27. MILLING TJ
    The Hard Bargain of Anticoagulation after Intracranial Haemorrhage, in the setting of Venous Thromboembolism: Between a rock and a hard place.
    Thromb Haemost. 2023 May 22. doi: 10.1055/a-2097-0775.
    PubMed     Abstract available
    
    
    
28. GIANNIS D, Goldin M, Rahman H, Sison CP, et al
    Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities.
    Thromb Haemost. 2023 May 5. doi: 10.1055/a-2087-3003.
    PubMed     Abstract available
    
    
    
29. XU K, Chan NC
    Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?
    Thromb Haemost. 2023;123:487-489.
    PubMed    
    
    
    April 2023
30. JOHNSEN SP, Jensen M, Munster AB, Frost L, et al
    Small-area analysis of treatment and clinical outcomes in patients with venous thromboembolism in Denmark: a nationwide cohort study.
    Thromb Haemost. 2023 Apr 13. doi: 10.1055/a-2073-4336.
    PubMed     Abstract available
    
    
    
31. GORMAN J, Candeloro M, Schulman S
    Anticoagulant management and outcomes in non-traumatic intracranial hemorrhage complicated by venous thromboembolism: a retrospective chart review.
    Thromb Haemost. 2023 Apr 4. doi: 10.1055/a-2068-6464.
    PubMed     Abstract available
    
    
    March 2023
32. KONSTANTINIDES S
    Modern lung scintigraphy techniques for optimising the diagnosis of pulmonary embolism: Great expectations, still waiting to be met.
    Thromb Haemost. 2023 Mar 19. doi: 10.1055/a-2057-8672.
    PubMed     Abstract available
    
    
    February 2023
33. HU S, Tan JS, Hu MJ, Guo TT, et al
    The Causality between Diabetes with Venous Thromboembolism: A Bidirectional Two-sample Mendelian Randomization Study.
    Thromb Haemost. 2023 Feb 22. doi: 10.1055/a-2040-4850.
    PubMed     Abstract available
    
    
    
34. BIKDELI B, Lo YC, Khairani C, Bejjani A, et al
    Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study.
    Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3222.
    PubMed     Abstract available
    
    
    
35. BECATTINI C, Agnelli G, Maggioni AP, Dentali F, et al
    CONTEMPORARY MANAGEMENT AND CLINICAL COURSE OF ACUTE PULMONARY EMBOLISM: THE COPE STUDY.
    Thromb Haemost. 2023 Feb 9. doi: 10.1055/a-2031-3859.
    PubMed     Abstract available
    
    
    January 2023
36. MARTIN-FERNANDEZ L, Garcia-Martinez I, Lopez S, Martinez-Perez A, et al
    Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.
    Thromb Haemost. 2023 Jan 25. doi: 10.1055/s-0043-1760844.
    PubMed     Abstract available
    
    
    
37. HWANG HG, Lee JH, Bang SM
    Incidence of Pregnancy-associated Venous Thromboembolism: Second Nationwide Study.
    Thromb Haemost. 2023 Jan 24. doi: 10.1055/a-2019-0607.
    PubMed     Abstract available
    
    
    
38. SCHENKER C, Stalder O, Mean M, Tritschler T, et al
    Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials.
    Thromb Haemost. 2023 Jan 9. doi: 10.1055/s-0042-1760365.
    PubMed     Abstract available
    
    
    December 2022
39. GOUALOU M, Noumegni S, de Moreuil C, Le Guillou M, et al
    Venous Thromboembolism Associated with Assisted Reproductive Technology: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2022 Dec 31. doi: 10.1055/s-0042-1760255.
    PubMed     Abstract available
    
    
    
40. RONNOW SAND J, Troelsen FS, Nagy D, Farkas DK, et al
    Increased Cancer Risk in Patients with Kidney Disease and Venous Thromboembolism: A Population-Based Cohort Study.
    Thromb Haemost. 2022 Dec 27. doi: 10.1055/s-0042-1759879.
    PubMed     Abstract available
    
    
    
41. MCBANE II RD, Vlazny DT, Houghton D, Casanegra AI, et al
    Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
    Thromb Haemost. 2022 Dec 27. doi: 10.1055/s-0042-1758835.
    PubMed     Abstract available
    
    
    
42. TRZEPIZUR W, Gerves C, Heudes B, Blanchard M, et al
    Sleep apnea and incident unprovoked venous thromboembolism: data from the Pays de la Loire sleep cohort.
    Thromb Haemost. 2022 Dec 19. doi: 10.1055/a-2000-8288.
    PubMed     Abstract available
    
    
    
43. GRANDONE E, Ageno W
    The legacy of Edwards and Steptoe and the windy roads of Assisted Reproduction: where do we stand with Venous Thromboembolism?
    Thromb Haemost. 2022 Dec 10. doi: 10.1055/a-1996-1341.
    PubMed     Abstract available
    
    
    November 2022
44. SQUIZZATO A, Venturini A, Pelitti V, Bellini B, et al
    Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected pulmonary embolism: a systematic review and meta-analysis.
    Thromb Haemost. 2022 Nov 24. doi: 10.1055/a-1986-8878.
    PubMed     Abstract available
    
    
    
45. TSCHARRE M, Wittmann F, Kitzmantl D, Schloglhofer T, et al
    Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices.
    Thromb Haemost. 2022 Nov 19. doi: 10.1055/a-1983-0676.
    PubMed     Abstract available
    
    
    
46. WANG J, Tan JS, Hua L, Sheng Q, et al
    Genetic predisposition of both waist circumference and hip circumference increased the risk of venous thromboembolism.
    Thromb Haemost. 2022 Nov 16. doi: 10.1055/a-1980-8852.
    PubMed     Abstract available
    
    
    
47. GURUNATHAN U, Barras M, McDougall C, Nandurkar H, et al
    Obesity and the Risk of Venous Thromboembolism after Major Lower Limb Orthopaedic Surgery: A Literature Review.
    Thromb Haemost. 2022 Nov 16. doi: 10.1055/s-0042-1757200.
    PubMed     Abstract available
    
    
    October 2022
48. SANCHEZ O, Konstantinides SV
    Does Fibrinolytic Strategy of Pulmonary Embolism International ThrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?
    Thromb Haemost. 2022 Oct 28. doi: 10.1055/s-0042-1756356.
    PubMed    
    
    
    
49. CARMONA-BAYONAS A, Verso M, Sanchez Canovas M, Rubio Perez J, et al
    Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.
    Thromb Haemost. 2022;122:1653-1661.
    PubMed     Abstract available
    
    
    September 2022
50. ORDING AG, Skjoth F, Andersen SD, Larsen TB, et al
    Adverse Events and All-Cause Mortality in Danish Patients with Cerebral Venous Thrombosis: A Nationwide Cohort Study.
    Thromb Haemost. 2022;122:1524-1531.
    PubMed     Abstract available
    
    
    August 2022
51. FORET T, Dufrost V, Heymonet M, Risse J, et al
    Circulating endothelial cells are associated with thromboembolic events in patients with antiphospholipid antibodies.
    Thromb Haemost. 2022 Aug 17. doi: 10.1055/a-1926-0453.
    PubMed     Abstract available
    
    
    July 2022
52. GUNER A, Kahraman S, Erturk M
    Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?
    Thromb Haemost. 2022 Jul 12. doi: 10.1055/a-1897-7141.
    PubMed     Abstract available
    
    
    
53. GOROG DA, Gue YX, Chao TF, Fauchier L, et al
    Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.
    Thromb Haemost. 2022 Jul 6. doi: 10.1055/s-0042-1750385.
    PubMed     Abstract available
    
    
    
54. CHI G, Lee JJ, Sheng S, Marszalek J, et al
    Systematic Review and Meta-Analysis of Thromboprophylaxis with Heparins Following Intracerebral Hemorrhage.
    Thromb Haemost. 2022;122:1159-1168.
    PubMed     Abstract available
    
    
    June 2022
55. MA Z, Sun X, Zhang Y, Li H, et al
    Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials.
    Thromb Haemost. 2022 Jun 30. doi: 10.1055/s-0042-1749185.
    PubMed     Abstract available
    
    
    
56. KIM SA, Lee JH, Lee JY, Hwang HG, et al
    Treatment and bleeding complications of cancer-associated venous thromboembolism: A Korean population-based study.
    Thromb Haemost. 2022 Jun 28. doi: 10.1055/a-1886-5991.
    PubMed     Abstract available
    
    
    
57. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
    Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
    Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
    PubMed     Abstract available
    
    
    May 2022
58. ZHANG YJ, Li ZH, Shen D, Zhang PD, et al
    Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study.
    Thromb Haemost. 2022 May 27. doi: 10.1055/s-0042-1744377.
    PubMed     Abstract available
    
    
    
59. JAKOBSEN L, Frischmuth T, Braekkan SK, Hansen JB, et al
    Joint effect of multiple prothrombotic genotypes and mean platelet volume on the risk of incident venous thromboembolism.
    Thromb Haemost. 2022 May 26. doi: 10.1055/a-1863-2052.
    PubMed     Abstract available
    
    
    April 2022
60. GRIS JR, Bouguignon C, Bouvier S, Cochery-Nouvellon E, et al
    PREGNANCY AFTER COMBINED ORAL CONTRACEPTIVE-ASSOCIATED VENOUS THROMBOEMBOLISM: AN INTERNATIONAL RETROSPECTIVE STUDY OF OUTCOMES.
    Thromb Haemost. 2022 Apr 26. doi: 10.1055/a-1835-8808.
    PubMed     Abstract available
    
    
    
61. D'APOLITO M, Ariano A, D'Andrea G, Tiscia G, et al
    Identification of the novel G250R variant indicates a role for Thrombomodulin in modulating the risk for venous thromboembolism.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-7109.
    PubMed     Abstract available
    
    
    
62. NOPP S, Pabinger I
    Growth Differentiation Factor-15: a Novel Biomarker for Predicting Risk of Venous Thromboembolism and Bleeding in Patients with Cancer.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-7328.
    PubMed     Abstract available
    
    
    March 2022
63. GABET A, Grave C, Tuppin P, Olie V, et al
    One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes.
    Thromb Haemost. 2022 Mar 14. doi: 10.1055/s-0042-1743475.
    PubMed     Abstract available
    
    
    
64. ROY DC, Wang TF, Mallick R, Carrier M, et al
    GDF-15, hs-TnT and NT proBNP for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy.
    Thromb Haemost. 2022 Mar 9. doi: 10.1055/a-1792-7720.
    PubMed     Abstract available
    
    
    February 2022
65. GOLDIN M, Koulas I, Weitz JI, Spyropoulos A, et al
    State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism.
    Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1778-1083.
    PubMed     Abstract available
    
    
    
66. LECUMBERRI R, Ruiz-Artacho P, Tzoran I, Brenner B, et al
    Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors.
    Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1777-4006.
    PubMed     Abstract available
    
    
    
67. PLANQUETTE B, Khider L, Le Berre A, Soudet S, et al
    Adjusting D-dimer to lung disease extent to exclude Pulmonary Embolism in COVID-19 patients (Co-LEAD).
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4371.
    PubMed     Abstract available
    
    
    January 2022
68. RIVAS A, Lauw MN, Bonin-Schnabel R, Crowther M, et al
    Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
    Thromb Haemost. 2022 Jan 19. doi: 10.1055/a-1745-2083.
    PubMed     Abstract available
    
    
    
69. CHEONG MA, Chew KM
    All that clots is not blood: Bone cement implantation syndrome presenting as an intracardiac mass and pulmonary embolism.
    Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1777.
    PubMed     Abstract available
    
    
    
70. BERTOLETTI L, Gusto G, Khachatryan A, Quignot N, et al
    Effectiveness and safety of oral anticoagulants in the treatment of acute venous thromboembolism: A nationwide comparative cohort study in France.
    Thromb Haemost. 2022 Jan 4. doi: 10.1055/a-1731-3922.
    PubMed     Abstract available
    
    
    December 2021
71. FLORIN J, Stalder O, Baumgartner C, Mean M, et al
    Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?
    Thromb Haemost. 2021 Dec 28. doi: 10.1055/s-0041-1740184.
    PubMed     Abstract available
    
    
    
72. COHEN AT, Sah J, Dhamane AD, Lee T, et al
    Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
    Thromb Haemost. 2021 Dec 28. doi: 10.1055/s-0041-1740254.
    PubMed     Abstract available
    
    
    
73. DUBOIS-SILVA A, Barbagelata-Lopez C, Pineiro-Parga P, Francisco I, et al
    Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs.
    Thromb Haemost. 2021;121:1650-1659.
    PubMed     Abstract available
    
    
    November 2021
74. ROTHBERG MB, Hamilton A, Greene MT, Fox J, et al
    Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6506.
    PubMed     Abstract available
    
    
    
75. EVENSEN LH, Arnesen CAL, Rosendaal FR, Gabrielsen ME, et al
    The risk of venous thromboembolism attributed to established prothrombotic genotypes.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6717.
    PubMed     Abstract available
    
    
    
76. ZHOU C, Yi Q, Ge H, Wei H, et al
    Validation of risk assessment models predicting venous thromboembolism in inpatients with AECOPD: a multicenter cohort study.
    Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1693-0063.
    PubMed     Abstract available
    
    
    
77. KHAN F, Rahman A, Tritschler T, Carrier M, et al
    Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.
    Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
    PubMed     Abstract available
    
    
    September 2021
78. SANCHEZ O, Charles-Nelson A, Ageno W, Barco S, et al
    Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism: Rationale and design of the PEITHO-3 trial.
    Thromb Haemost. 2021 Sep 24. doi: 10.1055/a-1653-4699.
    PubMed     Abstract available
    
    
    
79. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
    The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
    Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
    PubMed     Abstract available
    
    
    
80. MAHE I, Agnelli G, Ay C, Bamias A, et al
    Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study.
    Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896.
    PubMed     Abstract available
    
    
    
81. AGNELLI G, Munoz A, Franco L, Mahe I, et al
    Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/s-0041-1735194.
    PubMed     Abstract available
    
    
    
82. BIKDELI B, Hogan H, Morrison R, Fanikos J, et al
    Extended-Duration Low-intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism: Design of the HI-PRO Trial.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/a-1646-2244.
    PubMed     Abstract available
    
    
    August 2021
83. GABARIN N, Patterson S, Pai M, Afzaal T, et al
    Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Thromb Haemost. 2021 Aug 12. doi: 10.1055/a-1585-6182.
    PubMed     Abstract available
    
    
    July 2021
84. VALERIO L, Fedeli U, Schievano E, Avossa F, et al
    Decline in overall pulmonary embolism-related mortality and increasing prevalence of cancer-associated events in the Veneto region (Italy), 2008-2019.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4948.
    PubMed     Abstract available
    
    
    
85. RIEDL JM, Schwarzenbacher E, Moik F, Horvath L, et al
    Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing 1st-line chemotherapy with FOLFIRINOX or Gemcitabine/nab-paclitaxel.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4847.
    PubMed     Abstract available
    
    
    
86. NOUMEGNI SR, Hoffmann C, Tromeur C, Didier R, et al
    Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732300.
    PubMed     Abstract available
    
    
    
87. FRISCHMUTH T, Hindberg K, Aukrust P, Ueland T, et al
    Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732295.
    PubMed     Abstract available
    
    
    June 2021
88. VAN DE BRUG A, De Winter M, Ten Wolde M, Kaasjager K, et al
    Deciding on treatment duration for unprovoked venous thromboembolism: what is important to patients?
    Thromb Haemost. 2021 Jun 24. doi: 10.1055/a-1535-8726.
    PubMed     Abstract available
    
    
    
89. BONNESEN K, Schmidt M, Horvath-Puho E, Sorensen HT, et al
    The interaction effect between comorbidity and venous thromboembolism on mortality rates after venous thromboembolism: A 5-year cohort study.
    Thromb Haemost. 2021 Jun 11. doi: 10.1055/a-1527-6215.
    PubMed     Abstract available
    
    
    
90. MORA D, Nieto JA, Mateo J, Bikdeli B, et al
    Machine learning to predict outcomes in patients with acute pulmonary embolism who prematurely discontinued anticoagulant therapy.
    Thromb Haemost. 2021 Jun 9. doi: 10.1055/a-1525-7220.
    PubMed     Abstract available
    
    
    May 2021
91. HENDRIKS S, Bistervels I, Eijsvogel M, Faber L, et al
    Home treatment compared to initial hospitalization in patients with acute pulmonary embolism in the Netherlands: a cost analysis.
    Thromb Haemost. 2021 May 26. doi: 10.1055/a-1518-1847.
    PubMed     Abstract available
    
    
    
92. FRISCHMUTH T, Hindberg K, Gabrielsen ME, Brumpton BM, et al
    Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism.
    Thromb Haemost. 2021 May 3. doi: 10.1055/a-1497-9777.
    PubMed     Abstract available
    
    
    April 2021
93. FREI AN, Stalder O, Limacher A, Mean M, et al
    Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Thromb Haemost. 2021 Apr 30. doi: 10.1055/s-0041-1726345.
    PubMed     Abstract available
    
    
    
94. PASTORI D, Agnelli G
    Risk Scores for Death in Patients with Cancer-related Venous Thromboembolism: Still a Long Road Ahead.
    Thromb Haemost. 2021 Apr 22. doi: 10.1055/s-0041-1727244.
    PubMed    
    
    
    
95. GIRARD P, Laporte S, Chapelle C, Falvo N, et al
    Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.
    Thromb Haemost. 2021 Apr 20. doi: 10.1055/a-1486-7497.
    PubMed     Abstract available
    
    
    
96. MOOR J, Baumgartner C, Mean M, Stalder O, et al
    Validation of the 2019 European Society of Cardiology risk stratification algorithm for pulmonary embolism in normotensive elderly patients.
    Thromb Haemost. 2021 Apr 6. doi: 10.1055/a-1475-2263.
    PubMed     Abstract available
    
    
    February 2021
97. HOSKIN S, Brieger D, Chow V, Kritharides L, et al
    Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort Study.
    Thromb Haemost. 2021 Feb 28. doi: 10.1055/s-0041-1725932.
    PubMed     Abstract available
    
    
    
98. HERRERA-RIVERO M, Stoll M, Hegenbarth JC, Ruhle F, et al
    Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 16. doi: 10.1055/s-0041-1723988.
    PubMed     Abstract available
    
    
    
99. KING A, Leider H, Herman D, Malinowski AK, et al
    Patient- and Health-Care-Provider-Reported Outcomes to Consider in Research on Pregnancy-Associated Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 10. doi: 10.1055/s-0041-1722855.
    PubMed     Abstract available
    
    
    
100. KUCZMIK W, Wysokinski WE, Hesley GK, Vlazny DT, et al
     Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis.
     Thromb Haemost. 2021;121:216-223.
     PubMed     Abstract available
     
     
     January 2021
101. COHEN SL, Gianos E, Barish MA, Chatterjee S, et al
     Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
     Thromb Haemost. 2021 Jan 20. doi: 10.1055/a-1366-9656.
     PubMed     Abstract available
     
     
     
102. LI XQ, Hu YH, Lin P, Zhang JR, et al
     Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
     Thromb Haemost. 2021 Jan 15. doi: 10.1055/a-1355-3549.
     PubMed     Abstract available
     
     
     
103. ORIONE C, Tromeur C, Le Mao R, Le Floch PY, et al
     The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
     Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722190.
     PubMed     Abstract available
     
     
     
104. WENDELBOE AM, Campbell J, Ding K, Bratzler DW, et al
     Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
     Thromb Haemost. 2021 Jan 10. doi: 10.1055/s-0040-1722189.
     PubMed     Abstract available
     
     
     December 2020
105. LE MAO R, Jimenez D, Bikdeli B, Porres-Aguilar M, et al
     Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism.
     Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721506.
     PubMed     Abstract available
     
     
     
106. ELIAS A, Aronson D
     Risk of Acute Kidney Injury after Intravenous Contrast Media Administration in Patients with Suspected Pulmonary Embolism: A Propensity-Matched Study.
     Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721387.
     PubMed     Abstract available
     
     
     
107. PROIETTI M, Rivera-Caravaca JM, Esteve-Pastor MA, Marin F, et al
     Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
     Thromb Haemost. 2020 Dec 9. doi: 10.1055/a-1333-4448.
     PubMed     Abstract available
     
     
     November 2020
108. ZOLLER BA, Svensson P, Huang W, Ji J, et al
     Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
     Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
     PubMed     Abstract available
     
     
     
109. SPIRK D, Sebastian T, Barco S, Banyai M, et al
     Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
     Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720977.
     PubMed     Abstract available
     
     
     
110. AGENO W, Vedovati MC, Cohen A, Huisman M, et al
     Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study.
     Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720975.
     PubMed     Abstract available
     
     
     
111. ZABCZYK M, Natorska J, Janion-Sadowska A, Metzgier-Gumiela A, et al
     Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
     Thromb Haemost. 2020 Nov 13. doi: 10.1055/s-0040-1718762.
     PubMed     Abstract available
     
     
     
112. COHEN A, Keshishian A, Lee T, Wygant G, et al
     Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
     Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718728.
     PubMed     Abstract available
     
     
     October 2020
113. SCHULMAN S, Hu Y, Konstantinides S
     Venous Thromboembolism in COVID-19.
     Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718532.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.